Michael Warren

Michael Warren has extensive work experience in the pharmaceutical and biotechnology industry. Michael started their career at ArQule, Inc as a Research Scientist, where they developed cell proliferation and cytotoxicity assays. Michael then joined NitroMed as a Senior Research Associate, specializing in studying nitric-oxide metabolomics for small molecule vascular drug discovery. After that, they worked at Pfizer Pharmaceuticals as a Research Scientist II, focusing on GPCR targets and new technologies in the areas of diabetes and metabolic disease. Following Pfizer, they joined FORMA Therapeutics as a Principal Research Associate. In 2015, they joined Surface Oncology Inc, where they served in various roles including Scientist, Senior Scientist, and Principal Scientist. Most recently, they worked at InduPro as a Principal Scientist.

Michael Warren earned a Bachelor of Science degree in Biochemistry from the University of New Hampshire, completing their studies from 1992 to 1996. Following that, they pursued a Master of Science degree in Biotechnology/Biology at the University of Massachusetts Lowell, from 1996 to 1999.